When medication has helped only a little, caused difficult side effects, or stopped helping, the next step deserves a careful review. Depression treatment in Portage, MI can include psychotherapy, a medication change, TMS, Spravato, or a combination of approaches. The right plan depends on the diagnosis, earlier treatment, medical history, current safety, daily responsibilities, and what a patient can realistically complete.
Quick guide
What depression treatment in Portage, MI starts with
A useful evaluation does more than count medication names. The clinician needs to understand which symptoms remain, how they affect work and home life, and whether the original diagnosis still fits. Sleep problems, anxiety, trauma, substance use, medical conditions, and medicines prescribed for other reasons can all influence the plan.
The review should also cover past periods of unusually high energy, a reduced need for sleep, impulsive decisions, psychotic symptoms, hospital care, and family psychiatric history. These details may change which treatments are appropriate. Current symptoms and safety take priority over completing a routine checklist.
Bring the practical history, even if it is incomplete. A pharmacy printout, old patient-portal list, discharge summary, or note from a former prescriber can help reconstruct what was tried and why it changed.
Check whether earlier medication trials were adequate
For each antidepressant, write down the approximate dose, how long it was taken, any benefit, side effects, and the reason it stopped. Note whether missed doses, cost, pregnancy planning, another medical condition, or an interaction affected the trial. That context matters more than producing a perfect list from memory.
The National Institute of Mental Health notes that antidepressants generally take four to eight weeks to work, with sleep, appetite, and concentration sometimes improving before mood. The time needed for an individual trial is a prescribing decision; patients should not increase, reduce, or stop medication without speaking with the clinician who manages it.[1]
Treatment-resistant depression is often used to describe depression that has not improved after at least two adequate antidepressant trials.[1] Insurers and treatment programs may define the required history more specifically. A clinical diagnosis and an insurance authorization are separate decisions.
Options when medication has not helped enough
Psychotherapy and combined care
Psychotherapy can address patterns that medication alone does not change, including avoidance, loss of routine, relationship stress, and ways of responding to difficult thoughts. Some patients begin therapy for the first time; others adjust the type, frequency, or goals of treatment. NIMH describes psychotherapy, medication, or a combination of the two as common approaches to depression care.[1]
Medication changes
A prescriber may consider switching medication, adding another medicine, addressing side effects, or treating a related sleep, anxiety, or medical problem. The choice depends on the full medication list, health history, previous response, and patient preference. This article cannot determine which medicine or combination is safe for an individual.
TMS
Transcranial magnetic stimulation uses magnetic pulses delivered through a coil placed against the scalp. It is noninvasive and does not require anesthesia. NIMH describes a typical repetitive TMS course as treatment five days a week for four to six weeks, with sessions lasting about three to 40 minutes depending on the device and protocol.[2]
An FDA-cleared indication for the NeuroStar system includes adults with major depressive disorder who did not achieve satisfactory improvement from antidepressant medication in the current episode.[3] Device clearance does not establish candidacy or coverage for a particular patient. Review how TMS treatment works before the evaluation, then ask what protocol and visit schedule would apply to you.
Spravato
Spravato is a prescription nasal spray administered under direct observation in a certified healthcare setting. Current FDA labeling includes treatment-resistant depression in adults, either by itself or with an oral antidepressant. The label requires monitoring for at least two hours after each treatment, and patients need transportation home.[4]
The induction schedule in the prescribing information is twice weekly for four weeks, with later frequency based on the label and clinical response.[4] Learn about monitored Spravato treatment in Portage, including the time and transportation involved.
More than one option may be reasonable. A psychiatrist weighs diagnosis, safety, earlier response, appointment frequency, transportation, cost, and patient preference. No treatment can be promised to work, and the practical demands of a course matter.
Plan treatment around the Portage office
Kalamazoo TMS & Behavioral Health is located at 5930 Lovers Lane, third floor, Portage, Michigan 49002. Patients may be traveling from elsewhere in Portage, Kalamazoo, Oshtemo, Texas Township, Mattawan, Battle Creek, or another Southwest Michigan community.
Put the proposed schedule on a real calendar before treatment begins. Include drive time, check-in, parking, work, school pickup, caregiving, winter weather, and the length of the appointment. For Spravato, include the observation period and a responsible adult who can drive you home. For TMS, ask how many visits are expected, how long each appointment usually takes, and whether the course includes taper visits.
The Portage treatment location page provides local office information. Repeated visits are easier to complete when transportation and schedule barriers are discussed before authorization.
Prepare records and insurance questions
Insurance plans may apply different prior-authorization requirements to office visits, TMS, Spravato, psychotherapy, and prescriptions. They may request records showing the diagnosis, previous medication trials, therapy history, symptom scores, and safety screening. An authorization is not a guarantee that every charge will be paid.
Review the practice’s insurance and payment information. Call the member-services number on your insurance card and ask whether Kalamazoo TMS & Behavioral Health is in network for the exact service under consideration. Ask about the deductible, copay, coinsurance, site-of-care rules, and whether the plan has separate medical and pharmacy benefits.
Bring your insurance card, photo identification, current medication list, pharmacy history if available, and contact information for recent clinicians. The office can tell you which additional records are needed for the clinical review or a plan’s authorization process.
When symptoms need urgent help
Do not wait for a routine new-patient appointment if you have suicidal thoughts with a plan or intent, cannot stay safe, are unable to care for basic needs, or are experiencing severe agitation, confusion, or psychotic symptoms. Call or text 988 for the Suicide & Crisis Lifeline, call 911, or go to the nearest emergency department. Tell a trusted person what is happening and avoid being alone while arranging help.
Questions to bring to the first visit
- Does my current diagnosis still fit my symptoms and treatment history?
- Were my earlier medication trials long enough and at an adequate dose?
- What medical, neurological, or psychiatric safety concern matters most for me?
- Which options are reasonable now, and what evidence supports them?
- What appointment schedule and transportation would each option require?
- How will we measure symptoms and daily functioning over time?
- What records does my insurer need before it reviews authorization?
- What should I do if symptoms worsen while we are planning care?
Ask for written next steps if concentration or memory is difficult. A family member or trusted support person can also help record the plan, with your permission.
Frequently asked questions
How many antidepressants should I try before discussing other options?
There is no single count that determines the right next step for every patient. Treatment-resistant depression is commonly described after at least two adequate antidepressant trials, but the diagnosis, side effects, severity, safety, and patient preference also matter.[1] Insurers may use additional criteria.
Can I keep seeing my current therapist?
Often, yes. Ask how the psychiatric clinician and therapist can coordinate, what information can be shared with your written permission, and who will manage medication. The treatment plan should identify each clinician’s role.
Can I work during a TMS course?
Many patients plan treatment around work because TMS does not require anesthesia, but the appointment frequency can be demanding. Ask the office about the specific protocol, likely visit length, and individualized safety instructions before arranging your schedule.
Do I need a driver for every treatment option?
TMS itself does not involve sedation, though a person’s symptoms or other medicines may still affect driving. The FDA prescribing information for Spravato requires arranging transportation home and avoiding driving until the next day after a restful sleep.[4]
Does insurance cover advanced depression treatment?
Coverage varies by plan, diagnosis, treatment history, network, and prior authorization. Ask the office and insurer to verify the exact service. Do not rely on a general benefit summary as a payment guarantee.
Request a depression treatment evaluation in Portage, MI
A thoughtful plan for depression treatment in Portage, MI begins with the diagnosis, safety, earlier treatment, medical history, and the realities of repeated appointments. Bring the records you have; missing details can be identified during the review.
Request a new-patient evaluation with Kalamazoo TMS & Behavioral Health using the current patient form.
This article is educational and does not replace individualized medical advice, diagnosis, emergency care, or an insurer’s plan documents.
References
- National Institute of Mental Health: Depression, reviewed September 2024.
- National Institute of Mental Health: Brain Stimulation Therapies.
- U.S. Food and Drug Administration: NeuroStar Advanced Therapy System 510(k) Summary, K220127.
- U.S. Food and Drug Administration: Spravato full prescribing information, revised April 2025.
- U.S. Department of Veterans Affairs and Department of Defense: Clinical Practice Guideline for the Management of Major Depressive Disorder, February 2022.
